Log in
Enquire now
‌

US Patent 11084845 C-3 and C-17 modified triterpenoids as HIV-1 inhibitors

Patent 11084845 was granted and assigned to ViiV Healthcare on August, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
ViiV Healthcare
ViiV Healthcare
0
Current Assignee
ViiV Healthcare
ViiV Healthcare
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110848450
Patent Inventor Names
Yan Chen0
Richard A. Hartz0
Sing-Yuen Sit0
Alicia Regueiro-Ren0
Beata Nowicka-Sans0
Brian Lee Venables0
Ira B. Dicker0
Jacob Swidorski0
...
Date of Patent
August 10, 2021
0
Patent Application Number
201908070
Date Filed
August 7, 2019
0
Patent abstract

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11084845 C-3 and C-17 modified triterpenoids as HIV-1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us